Form 8-K - Current report:
SEC Accession No. 0001104659-20-077076
Filing Date
2020-06-26
Accepted
2020-06-26 07:05:32
Documents
3
Period of Report
2020-06-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2023528-1_8k.htm 8-K 19956
2 EXHIBIT 99.1 tm2023528d1_ex99-1.htm EX-99.1 20406
3 GRAPHIC tm2023528d1_ex99-1img01.jpg GRAPHIC 3530
  Complete submission text file 0001104659-20-077076.txt   46460
Mailing Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038
Business Address 200 BROADWAY, 3RD FLOOR NEW YORK NY 10038 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 20991118
SIC: 2834 Pharmaceutical Preparations